Every December, the San Antonio Breast Cancer Symposium brings together clinicians, researchers, and advocates to discuss the latest breast cancer study results. We’re proud to present our coverage below.
SABCS 2019: Five More Years of Femara Seems to Reduce Breast Cancer Recurrence Risk for Some Women
Terry Mamounas, M.D., MPH, FACS
SABCS 2019: MRI Finds Breast Cancers Earlier Than Mammography in Women With Strong Family History
Madeleine Tilanus-Linthorst, Ph.D.
Heard in the Halls Mini Episodes:
GRASP: Empowering Patients With Knowledge – Heard in the Halls: Voices From the 2019 SABCS
Felicia Johnson and Sharon Rivera-Sanchez
Mets, Sex, and Side Effects – Heard in the Halls: Voices From the 2019 SABCS
Kelly Shanahan, M.D.
Can we help guide you?
Create a profile for better recommendations
Tamoxifen (Brand Names: Nolvadex, Soltamox)
Tamoxifen is the oldest and most-prescribed selective estrogen receptor modulator (SERM)....
Breast Cancer Stages
The stage of a breast cancer is determined by the cancer’s characteristics, such as how large it...
Cancer Survivors Overestimate Quality of Their Diets
Most people who have been diagnosed with cancer think they eat a healthy diet, but a study found...